 Nathan Schoppa
Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Olfactory Bulb | 27 | 2025 | 137 | 9.260 |
Why?
| | Neural Inhibition | 11 | 2019 | 151 | 2.240 |
Why?
| | Neurons | 13 | 2019 | 1425 | 2.050 |
Why?
| | Synapses | 6 | 2025 | 379 | 1.890 |
Why?
| | Glutamic Acid | 6 | 2025 | 227 | 1.580 |
Why?
| | Action Potentials | 10 | 2021 | 463 | 1.470 |
Why?
| | Olfactory Receptor Neurons | 5 | 2021 | 70 | 1.420 |
Why?
| | Receptors, Metabotropic Glutamate | 3 | 2021 | 39 | 1.350 |
Why?
| | Dendrites | 7 | 2025 | 100 | 1.180 |
Why?
| | Olfactory Pathways | 5 | 2013 | 60 | 1.160 |
Why?
| | Rats, Sprague-Dawley | 18 | 2025 | 2308 | 1.120 |
Why?
| | Smell | 5 | 2013 | 132 | 1.090 |
Why?
| | Rats | 21 | 2025 | 5236 | 1.020 |
Why?
| | Excitatory Postsynaptic Potentials | 6 | 2014 | 109 | 1.010 |
Why?
| | Nerve Net | 6 | 2013 | 249 | 0.980 |
Why?
| | gamma-Aminobutyric Acid | 6 | 2014 | 154 | 0.870 |
Why?
| | Fragile X Syndrome | 1 | 2023 | 73 | 0.830 |
Why?
| | Patch-Clamp Techniques | 14 | 2016 | 259 | 0.820 |
Why?
| | Synaptic Transmission | 5 | 2015 | 258 | 0.760 |
Why?
| | Potassium Channels | 6 | 2001 | 139 | 0.730 |
Why?
| | Sensory Receptor Cells | 3 | 2021 | 94 | 0.700 |
Why?
| | Animals | 37 | 2025 | 34628 | 0.670 |
Why?
| | Gap Junctions | 2 | 2017 | 62 | 0.670 |
Why?
| | Receptors, Adrenergic | 2 | 2010 | 35 | 0.640 |
Why?
| | Interneurons | 6 | 2019 | 115 | 0.620 |
Why?
| | Adrenergic alpha-Agonists | 3 | 2012 | 30 | 0.560 |
Why?
| | In Vitro Techniques | 10 | 2017 | 1061 | 0.560 |
Why?
| | Signal Transduction | 3 | 2025 | 4857 | 0.550 |
Why?
| | Odorants | 6 | 2023 | 147 | 0.530 |
Why?
| | Norepinephrine | 3 | 2012 | 218 | 0.520 |
Why?
| | Receptors, AMPA | 4 | 2006 | 132 | 0.480 |
Why?
| | Piriform Cortex | 1 | 2014 | 5 | 0.460 |
Why?
| | Ion Channel Gating | 6 | 2001 | 85 | 0.400 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 4 | 2001 | 205 | 0.370 |
Why?
| | Electric Stimulation | 7 | 2010 | 266 | 0.360 |
Why?
| | Membrane Potentials | 10 | 2009 | 260 | 0.350 |
Why?
| | Biological Clocks | 1 | 2010 | 40 | 0.340 |
Why?
| | Inhibitory Postsynaptic Potentials | 3 | 2017 | 31 | 0.330 |
Why?
| | Olfactory Perception | 1 | 2009 | 22 | 0.330 |
Why?
| | Excitatory Amino Acid Antagonists | 6 | 2010 | 94 | 0.300 |
Why?
| | Mice, Knockout | 3 | 2023 | 2770 | 0.280 |
Why?
| | Receptors, Kainic Acid | 1 | 2006 | 10 | 0.280 |
Why?
| | Cerebral Cortex | 2 | 2015 | 407 | 0.270 |
Why?
| | Axons | 2 | 2006 | 181 | 0.260 |
Why?
| | Neuronal Plasticity | 2 | 2012 | 256 | 0.240 |
Why?
| | Brain Mapping | 1 | 2009 | 562 | 0.240 |
Why?
| | GABA Antagonists | 4 | 2010 | 31 | 0.240 |
Why?
| | Electrophysiology | 5 | 2008 | 205 | 0.240 |
Why?
| | Quinoxalines | 4 | 2010 | 64 | 0.240 |
Why?
| | Models, Neurological | 4 | 2009 | 233 | 0.240 |
Why?
| | Male | 11 | 2025 | 63146 | 0.230 |
Why?
| | GABAergic Neurons | 2 | 2014 | 28 | 0.210 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 2023 | 55 | 0.210 |
Why?
| | Autoreceptors | 1 | 2002 | 4 | 0.210 |
Why?
| | Cholecystokinin | 1 | 2021 | 14 | 0.190 |
Why?
| | Potassium Channels, Calcium-Activated | 1 | 2001 | 11 | 0.190 |
Why?
| | Neurotransmitter Agents | 1 | 2021 | 82 | 0.190 |
Why?
| | Lysine | 2 | 2016 | 266 | 0.180 |
Why?
| | Mice | 7 | 2023 | 16543 | 0.180 |
Why?
| | Mutation | 4 | 2015 | 3671 | 0.170 |
Why?
| | Animals, Newborn | 3 | 2010 | 813 | 0.170 |
Why?
| | Bicuculline | 2 | 2010 | 21 | 0.170 |
Why?
| | GABA-A Receptor Antagonists | 3 | 2010 | 16 | 0.160 |
Why?
| | Calcium Signaling | 1 | 2001 | 236 | 0.160 |
Why?
| | Potassium | 1 | 1999 | 140 | 0.160 |
Why?
| | Kinetics | 5 | 2001 | 1619 | 0.150 |
Why?
| | Organ Culture Techniques | 2 | 2013 | 144 | 0.150 |
Why?
| | Ion Channels | 3 | 1998 | 126 | 0.150 |
Why?
| | Microscopy, Electron | 2 | 2016 | 417 | 0.150 |
Why?
| | Nerve Tissue Proteins | 1 | 2001 | 568 | 0.140 |
Why?
| | Connexins | 1 | 2017 | 53 | 0.140 |
Why?
| | 3,3'-Diaminobenzidine | 1 | 2016 | 3 | 0.140 |
Why?
| | N-Methylaspartate | 2 | 2010 | 36 | 0.130 |
Why?
| | Female | 7 | 2019 | 68162 | 0.130 |
Why?
| | Models, Biological | 3 | 2017 | 1702 | 0.130 |
Why?
| | Vesicle-Associated Membrane Protein 2 | 1 | 2015 | 15 | 0.130 |
Why?
| | Reproducibility of Results | 1 | 2023 | 3042 | 0.130 |
Why?
| | Munc18 Proteins | 1 | 2015 | 23 | 0.130 |
Why?
| | Oocytes | 4 | 1998 | 178 | 0.120 |
Why?
| | Exocytosis | 1 | 2015 | 89 | 0.120 |
Why?
| | Microscopy, Fluorescence | 1 | 2016 | 404 | 0.120 |
Why?
| | Mice, Neurologic Mutants | 3 | 1998 | 20 | 0.110 |
Why?
| | Biotransformation | 3 | 1998 | 48 | 0.110 |
Why?
| | Xenopus laevis | 3 | 1998 | 99 | 0.110 |
Why?
| | Disease Models, Animal | 1 | 2023 | 3994 | 0.110 |
Why?
| | Imaging, Three-Dimensional | 1 | 2016 | 559 | 0.100 |
Why?
| | In Situ Hybridization | 1 | 2013 | 295 | 0.100 |
Why?
| | Brain Waves | 1 | 2012 | 30 | 0.100 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 79 | 0.100 |
Why?
| | 2-Amino-5-phosphonovalerate | 2 | 2001 | 10 | 0.090 |
Why?
| | Biophysical Phenomena | 1 | 2010 | 63 | 0.090 |
Why?
| | Pyridazines | 1 | 2010 | 48 | 0.080 |
Why?
| | Valine | 1 | 2010 | 78 | 0.080 |
Why?
| | Calcium | 2 | 2009 | 1173 | 0.080 |
Why?
| | Excitatory Amino Acid Agonists | 2 | 2001 | 39 | 0.080 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2073 | 0.080 |
Why?
| | Probability | 1 | 2009 | 313 | 0.080 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2008 | 131 | 0.080 |
Why?
| | Triazines | 1 | 2008 | 38 | 0.080 |
Why?
| | Electric Conductivity | 2 | 2002 | 94 | 0.080 |
Why?
| | Learning | 1 | 2012 | 381 | 0.070 |
Why?
| | Chlorides | 1 | 1989 | 138 | 0.070 |
Why?
| | Trachea | 1 | 1989 | 228 | 0.070 |
Why?
| | Piperidines | 1 | 2008 | 186 | 0.070 |
Why?
| | Cytoplasmic Granules | 1 | 2006 | 82 | 0.060 |
Why?
| | Age Factors | 1 | 2012 | 3133 | 0.060 |
Why?
| | Membrane Proteins | 1 | 1989 | 1100 | 0.050 |
Why?
| | Receptors, Odorant | 1 | 2002 | 38 | 0.050 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channels | 1 | 2001 | 11 | 0.050 |
Why?
| | Calcium Channels, N-Type | 1 | 2001 | 8 | 0.050 |
Why?
| | Time Factors | 2 | 2009 | 6568 | 0.050 |
Why?
| | Ion Transport | 1 | 2001 | 57 | 0.050 |
Why?
| | Periodicity | 1 | 2001 | 56 | 0.050 |
Why?
| | Mice, Inbred C57BL | 1 | 2012 | 5270 | 0.050 |
Why?
| | Aspartic Acid | 1 | 2001 | 79 | 0.050 |
Why?
| | Macromolecular Substances | 1 | 2001 | 212 | 0.050 |
Why?
| | Neural Pathways | 1 | 2002 | 288 | 0.040 |
Why?
| | 4-Aminopyridine | 1 | 1999 | 23 | 0.040 |
Why?
| | Sodium Channel Blockers | 1 | 1999 | 24 | 0.040 |
Why?
| | Potassium Channel Blockers | 1 | 1999 | 35 | 0.040 |
Why?
| | Sodium Channels | 1 | 1999 | 62 | 0.040 |
Why?
| | Feedback | 1 | 1999 | 156 | 0.040 |
Why?
| | Dizocilpine Maleate | 1 | 1998 | 16 | 0.040 |
Why?
| | Magnesium | 1 | 1998 | 151 | 0.040 |
Why?
| | Cycloleucine | 1 | 1997 | 3 | 0.040 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1997 | 15 | 0.040 |
Why?
| | Tetrodotoxin | 1 | 1997 | 38 | 0.040 |
Why?
| | Adenylyl Cyclases | 1 | 1997 | 83 | 0.040 |
Why?
| | Cadmium | 1 | 1997 | 67 | 0.030 |
Why?
| | Calcium Channels | 1 | 1997 | 148 | 0.030 |
Why?
| | Neuroprotective Agents | 1 | 1997 | 110 | 0.030 |
Why?
| | Cells, Cultured | 2 | 1997 | 4048 | 0.030 |
Why?
| | Membrane Fusion | 1 | 2015 | 39 | 0.030 |
Why?
| | SNARE Proteins | 1 | 2015 | 38 | 0.030 |
Why?
| | Immunoblotting | 1 | 2015 | 302 | 0.030 |
Why?
| | Liposomes | 1 | 2015 | 163 | 0.030 |
Why?
| | Receptors, Glycine | 1 | 1993 | 4 | 0.030 |
Why?
| | Baculoviridae | 1 | 1993 | 44 | 0.030 |
Why?
| | Binding Sites | 1 | 2015 | 1238 | 0.020 |
Why?
| | Humans | 2 | 2023 | 128896 | 0.020 |
Why?
| | Epilepsy | 1 | 2015 | 314 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 1992 | 391 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 1992 | 539 | 0.020 |
Why?
| | Drosophila melanogaster | 1 | 1992 | 217 | 0.020 |
Why?
| | Chloride Channels | 1 | 1989 | 38 | 0.020 |
Why?
| | Dogs | 1 | 1989 | 372 | 0.020 |
Why?
| | Receptors, GABA-A | 1 | 2001 | 93 | 0.010 |
Why?
| | Chromatography, Affinity | 1 | 1993 | 83 | 0.010 |
Why?
| | Moths | 1 | 1993 | 38 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1993 | 270 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 325 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1993 | 536 | 0.010 |
Why?
| | Blotting, Western | 1 | 1993 | 1188 | 0.010 |
Why?
| | Cell Membrane | 1 | 1993 | 728 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1993 | 2047 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1993 | 2842 | 0.000 |
Why?
| | Cell Line | 1 | 1993 | 2759 | 0.000 |
Why?
|
|
Schoppa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|